Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Inventory (2016 - 2025)

Fortress Biotech has reported Inventory over the past 10 years, most recently at $10.6 million for Q4 2025.

  • Quarterly results put Inventory at $10.6 million for Q4 2025, down 28.93% from a year ago — trailing twelve months through Dec 2025 was $10.6 million (down 28.93% YoY), and the annual figure for FY2025 was $10.6 million, down 28.93%.
  • Inventory for Q4 2025 was $10.6 million at Fortress Biotech, down from $11.8 million in the prior quarter.
  • Over the last five years, Inventory for FBIO hit a ceiling of $16.1 million in Q1 2022 and a floor of $2.3 million in Q1 2021.
  • Median Inventory over the past 5 years was $12.0 million (2023), compared with a mean of $12.1 million.
  • Biggest five-year swings in Inventory: soared 1084.04% in 2021 and later dropped 28.93% in 2025.
  • Fortress Biotech's Inventory stood at $9.9 million in 2021, then skyrocketed by 43.57% to $14.2 million in 2022, then decreased by 27.92% to $10.2 million in 2023, then surged by 46.42% to $14.9 million in 2024, then dropped by 28.93% to $10.6 million in 2025.
  • The last three reported values for Inventory were $10.6 million (Q4 2025), $11.8 million (Q3 2025), and $13.6 million (Q2 2025) per Business Quant data.